
×
Inhaltsverzeichnis
- 1. Genetics of RAS Signaling in Drosophila.
- I. Introduction.
- II. Background to the Experimental Systems.
- III. Protein Tyrosine Kinase Receptors.
- IV. Linking RAS with Tyrosine Kinase Receptors.
- V. A Kinase Cascade Downstream of RAS.
- VI. Nuclear Events.
- VII. Concluding Remarks.
- 2. RAS-Mediated Signal Transduction in C. elegans.
- II. Genetic Approaches Used to Study Vulval Signal Transduction.
- III. Genetic and Molecular Analysis of the let-60 RAS Gene.
- IV. Genes Acting Upstream of RAS.
- V. Genes Acting Downstream of RAS.
- VI. Multiple Functions of the let-60 RAS-mediated Signal Transduction Pathway During C elegans Development.
- 3. Mammals I: Regulation of RAS Activation.
- II. Growth Factor/Cytokine Signaling.
- III. Growth Factor Cascades: Autocrine Stimulation.
- 4. Prenylation of RAS and Inhibitors of Prenyltransferases.
- II. C-Terminal Modification of RAS Proteins.
- III. Farnesyltransferase and Geranylgeranyltransferases.
- IV. Mutational Analyses of Prenyltransferases.
- V. Inhibitors of Prenylation.
- VI. Biological Effects of Prenyltransferase Inhibitors.
- 5. Mammals II: Downstream of RAS and Actin-Cytoskeleton.
- I. RAS GAPs.
- II. Oncogenic Mutations of RAS.
- III. Effectors of RAS.
- IV. Actin-Cytoskeleton.
- V. G Proteins in the Rho Family (Rho, Rac and CDC42).
- VI. RAS-Activated or -Repressed Genes.
- 6. From RAS to MAPK: Cell-Free Assay System for RAS- and Rap 1-Dependent B-Raf Activation.
- II. Cell-free Assay System for the RAS-dependent Activation of the MAP Kinase Cascade in Xenopus Oocyte Cytosol.
- III. REKS.
- IV. Raf Activation.
- V. Conclusion.




